Epidarex Capital is a transatlantic venture capital firm specializing in early-stage investments to build life science companies in emerging hubs. Leveraging deep scientific and industry networks, the company focuses on transformative healthcare technologies and services, aiming to create value and shared success. Epidarex Capital is known for partnering with universities and research institutions, particularly in the US and UK, to fund innovative ideas and develop novel drugs and medical devices.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →